Clenziderm Pore Therapy Liquid
Product Images NDC 62032-612

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Clenziderm Pore Therapy (NDC 62032-612). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Obagi Cosmeceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Kit Carton)

This text provides information about a skincare product called "OBAGI S SKINTRINSIQ CLARIFYING PROTOCOLKIT." The kit includes 30 treatments, but no information is given on the specific items included in the package.*

FDA Label Image

Principal Display Panel (148 mL Bottle Label)

This is a description of a skincare product called "Pore Therapy" that contains 2% Salicylic Acid as an acne treatment. The text includes drug facts and directions for use. There is also a list of other ingredients; however, some of the characters are not readable through .*

FDA Label Image

Principal Display Panel (85 g Tube Carton)

This appears to be a description of a sunscreen product called "Sun Shield Mineral Broad Spectrum SPF 50" manufactured by a company called Obagi Medical. The text provides drug facts, inactive ingredients, directions for use, and other information such as a customer service helpline and a warning about keeping it away from children. Some of the inactive ingredients include Popmychoystean, Seareth-21, Prpanedi, and Topsechum Wi. The product is labeled as non-comedogenic and dermatologist tested.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.